JP Morgan Chase’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-1,748,795
| Closed | -$321M | – | 7096 |
|
|
2021
Q2 | $321M | Sell |
1,748,795
-515,586
| -23% | -$88.5M | 0.04% | 463 |
|
|
2021
Q1 | $346M | Sell |
2,264,381
-2,047,029
| -47% | -$317M | 0.05% | 405 |
|
|
2020
Q4 | $674M | Buy |
4,311,410
+111,699
| +3% | +$14.4M | 0.11% | 217 |
|
|
2020
Q3 | $472M | Buy |
4,199,711
+374,895
| +10% | +$40.4M | 0.09% | 245 |
|
|
2020
Q2 | $429M | Buy |
3,824,816
+870,182
| +29% | +$92.4M | 0.09% | 246 |
|
|
2020
Q1 | $265M | Sell |
2,954,634
-1,924,705
| -39% | -$189M | 0.07% | 300 |
|
|
2019
Q4 | $528M | Buy |
4,879,339
+115,109
| +2% | +$12.3M | 0.11% | 217 |
|
|
2019
Q3 | $467M | Buy |
4,764,230
+1,699,323
| +55% | +$192M | 0.1% | 240 |
|
|
2019
Q2 | $387M | Sell |
3,064,907
-1,676,974
| -35% | -$216M | 0.08% | 278 |
|
|
2019
Q1 | $641M | Buy |
4,741,881
+380,208
| +9% | +$47.3M | 0.14% | 171 |
|
|
2018
Q4 | $425M | Buy |
4,361,673
+791,885
| +22% | +$93.6M | 0.11% | 221 |
|
|
2018
Q3 | $496M | Buy |
3,569,788
+2,109,596
| +144% | +$265M | 0.1% | 227 |
|
|
2018
Q2 | $181M | Buy |
1,460,192
+643,387
| +79% | +$75.2M | 0.04% | 472 |
|
|
2018
Q1 | $91M | Sell |
816,805
-98,088
| -11% | -$11.7M | 0.02% | 674 |
|
|
2017
Q4 | $109M | Sell |
914,893
-879,832
| -49% | -$107M | 0.02% | 608 |
|
|
2017
Q3 | $248M | Buy |
1,794,725
+482,798
| +37% | +$65.6M | 0.06% | 353 |
|
|
2017
Q2 | $160M | Sell |
1,311,927
-1,758,935
| -57% | -$205M | 0.04% | 457 |
|
|
2017
Q1 | $372M | Buy |
3,070,862
+1,354,818
| +79% | +$175M | 0.09% | 244 |
|
|
2016
Q4 | $210M | Sell |
1,716,044
-3,924,465
| -70% | -$480M | 0.05% | 381 |
|
|
2016
Q3 | $691M | Buy |
5,640,509
+741,568
| +15% | +$95.5M | 0.18% | 132 |
|
|
2016
Q2 | $572M | Sell |
4,898,941
-208,444
| -4% | -$29.6M | 0.15% | 160 |
|
|
2016
Q1 | $711M | Buy |
5,107,385
+266,270
| +6% | +$39.1M | 0.19% | 133 |
|
|
2015
Q4 | $923M | Buy |
4,841,115
+66,466
| +1% | +$11.6M | 0.24% | 91 |
|
|
2015
Q3 | $747M | Sell |
4,774,649
-535,516
| -10% | -$97.7M | 0.21% | 112 |
|
|
2015
Q2 | $960M | Sell |
5,310,165
-226,771
| -4% | -$39.1M | 0.24% | 85 |
|
|
2015
Q1 | $960M | Sell |
5,536,936
-1,006,884
| -15% | -$182M | 0.23% | 94 |
|
|
2014
Q4 | $1.21B | Sell |
6,543,820
-225,216
| -3% | -$41.7M | 0.29% | 72 |
|
|
2014
Q3 | $1.12B | Sell |
6,769,036
-289,020
| -4% | -$47.5M | 0.28% | 73 |
|
|
2014
Q2 | $1.1B | Sell |
7,058,056
-299,755
| -4% | -$47.3M | 0.28% | 68 |
|
|
2014
Q1 | $1.12B | Buy |
7,357,811
+1,199,641
| +19% | +$191M | 0.31% | 63 |
|
|
2013
Q4 | $818M | Buy |
6,158,170
+1,069,078
| +21% | +$128M | 0.24% | 93 |
|
|
2013
Q3 | $591M | Buy |
5,089,092
+1,319,619
| +35% | +$145M | 0.18% | 129 |
|
|
2013
Q2 | $348M | Buy |
+3,769,473
| New | +$363M | 0.12% | 217 |
|
Other funds holding ALXN
BCI
NICM
TAIM
RG
CFO
MAM